Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Jan 25 2024
Business
Jan 25 2024
4 min read

Press Release Jan 25 2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 25, 2024, titled "Zydus receives Final Approval from the USFDA for Gabapentin Tablets (Once-Daily), 300 mg and 600 mg".

View Attachment